Healthcare
Ysios et al. raise €15.5m series-B for CorWave
Backers include existing shareholders Sofinnova Partners, BPI France and Seventure Partners
IK acquires ZytoService from Capiton
GP hopes to build on its previous experience in the healthcare sector
Mucap et al. in €10m Promethera series-C extension
Fresh capital will enable biotech company to invest in new product development
HealthCap et al. in SEK 327m round for Bonesupport
Round brings the total amount raised by the Swedish biotech company to more than SEK 750m
Caixa Capital Risc leads €1.5m round for Iproteos
Following the round, the company totals €3m of funding raised since its foundation in 2011
Nordic- and Avista-backed ConvaTec in £4.4bn IPO
Medical products company has been under the GPs' tenure for eight years
RJD acquires Barber from PHD and Enterprise
Deal represents 44.5% IRR for the vendors, four years after their initial investment
Palamon sells Sarquavitae to PAI portfolio company
Palamon reaps €140m in proceeds for a 3x money return following the sale to PAI
BC Partners buys 22 Priory Group clinics from Arcadia
GP acquires UK mental health facilities from the US group as part of regulatory compliance
GSO Capital, Siparex Intermezzo back Omega Group
M Capital Partners exits French nursing homes group after five-year holding
Chemelot leads €11m round for Fortimedix Surgical
Venture fund has been invested in the parent group of Fortimedix since 2004
Ratos-backed TFS acquires SCIderm
Acquisition comes after TFS and SCIderm entered into a strategic partnership in 2014
IK acquires German pharma group Aposan
Investment comes from IK Small Cap I Fund, which closed on €277m earlier this year
Nordic GPs look to new verticals in private healthcare
GPs in the region are increasingly turning to new healthcare subsectors as the private care segment evolves into a large-cap game
Life Sciences Partners in €17.5m Immunic series-A
Other participating investors included Bayern Kapital and High-Tech Gründerfonds
UK healthcare market still fighting fit post-Brexit
Momentous changes in the UK's healthcare provision space and the potential for growth in related subsectors present opportunities for private equity
SHS invests in spine implants producer EIT
Business hopes to use SHS's investment for an expansion to the US market
Inveready leads €3.5m round for Leukos Biotech
GP has drawn down capital from its Inveready Innvierte Biotech II vehicle
ArchiMed buys three French biotech businesses
As part of the deal, the GP has bought three French biotech businesses, Fyxteia, HIS and Polyplus
Imperial Innovations et al. in £25m series-A for Artios
Investment funds the spinout of the biotech business from Cancer Research UK
Gimv invests €30m in Spineart
Investment marks Gimv's fourth investment in the healthcare space this year
Healthcare: A case study in reputational risk
PE investments in Nordic healthcare have become a controversial topic following the 'Carema scandal', which sparked ESG and transparency reforms
Avoiding healthcare controversy and seeking new opportunities
As GPs shy away from investment in healthcare provision, new opportunities are presenting themselves in other medically related sub-sectors
Ardian to acquire Lagarrigue Group
Azulis Capital exits after taking a majority stake during the secondary buyout in 2011